Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.
Journal Information
Full Title: Mutagenesis
Abbreviation: Mutagenesis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Environmental Health
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The contribution of Covance Ltd staff in carrying out the cytogenetic studies reported in this article, is acknowledged, as is Accelera Pty Ltd for carrying out the Ames tests. Robert Don (DNDi) is thanked for his support of this work. We are grateful to Janssen Pharmaceutica N.V., Beerse, Belgium (a Johnson and Johnson Company) for supply of the flubendazole metabolites. The Drugs for Neglected Diseases initiative acknowledges financial support from the Bill & Melinda Gates Foundation (USA) for this work. The authors would like to acknowledge Dr John Wills (Health Canada post-doctoral fellow) who provided support in generating Figure 2."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025